Remove BioTech Remove Health Data Remove Primary Care
article thumbnail

The Retail Health Battle Royale in the U.S. – A Week-Long Brainstorm, Day 2 of 5 – Amazon and One Medical

Health Populi

As we all grapple with what this means at this preliminary stage and then what could evolve over time, I focus on the dual aspect of the opportunity: is this about primary care or is this about data? ” I added the bold emphasis here on the issue of personal health data. To be sure, it’s both.

article thumbnail

2021HealthTech IPO Rush: 20+ Digital Health companies went public in 2021 but where are they now?

Lloyd Price

Movano Health:A women's health company that develops and sells smart jewelry that tracks health data. IPO date of March 22, 2021 Movano Health in the last 2 years has focused on developing and gaining regulatory approval for the Evie Ring, a women's health smart ring.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

20+ Digital Health companies went public in 2021: Where are they now?

Lloyd Price

Movano Health: A women's health company that develops and sells smart jewelry that tracks health data. IPO date of March 22, 2021 Movano Health in the last 2 years has focused on developing and gaining regulatory approval for the Evie Ring, a women's health smart ring.

article thumbnail

Emerging trends in the European HealthTech M&A market 2023

Lloyd Price

This growth is expected to create opportunities for M&A activity, as pharmaceutical companies look to acquire smaller, innovative biotech companies. This trend is expected to continue in 2023, particularly in the areas of primary care, diagnostics, and hospital services.

article thumbnail

A Matter of Trust, Perception, Risk, and Uncertainty – The Big Issues Raised by the Acquisition of PatientsLikeMe and Other Patient Data Transactions

Health Populi

To address that challenge, in 2017 PLM secured a $100 million (controlling interest) investment from iCarbonX , a Chinese company that is amassing patient data to discover cures for disease. When this occurred, it didn’t cause more than a ripple of interest outside biotech. citizens’ personal data. But the U.S.